Dilapan-S versus Vaginal Misoprostol for Cervical Preparation before Diagnostic Hysteroscopy

Dilapan-S versus Vaginal Misoprostol for Cervical Preparation before Diagnostic Hysteroscopy: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202504875828484

Enrollment

Registered

2025-04-15

Start date

2022-09-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

Dialpin

Misoprostol

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1-Patients requiring diagnostic hysteroscopy for investigation of infertility. 2-Female patient aged > 18 yrs. old, requiring hysteroscopy with valid indication., 3- BMI less than 30 kg/m2 . 4-female patient with previous caesarean section (no history of vaginal delivery).

Exclusion criteria

Exclusion criteria: 1-BMI =30 kg/m2. 2-current pregnancy, cervical pregnancy. 3-pelvic inflammatory disease or bleeding tendency. 4-allergy to Dilapan or mesoprostol.

Design outcomes

Primary

Measure	Time frame
Ease of cervical entry, fulfilled by the gynaecologist, a 5-point Likert scale (very difficult = 1, difficult = 2, fair = 3, easy = 4, and very easy = 5) will be used to determine the feasibility of hysteroscopy entry into the cervix.	—

Secondary

Measure	Time frame
The secondary outcome was the pain felt during the hysteroscopy,. A 10-point visual analog scale (VAS)was used to determine the pain score among the studied cases.	—

Countries

Egypt

Contacts

Public Contactahmed sherif

doctor

ahmedgyna@yahoo.com00201117008040

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026